232 related articles for article (PubMed ID: 10225286)
21. Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of
Holubova J; Juhasz A; Masin J; Stanek O; Jurnecka D; Osickova A; Sebo P; Osicka R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769101
[TBL] [Abstract][Full Text] [Related]
22. Structural requirement of the hydrophobic region of the Bordetella pertussis CyaA-hemolysin for functional association with CyaC-acyltransferase in toxin acylation.
Raksanoh V; Prangkio P; Imtong C; Thamwiriyasati N; Suvarnapunya K; Shank L; Angsuthanasombat C
Biochem Biophys Res Commun; 2018 May; 499(4):862-867. PubMed ID: 29625104
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
24. Repeat sequences in the Bordetella pertussis adenylate cyclase toxin can be recognized as alternative carboxy-proximal secretion signals by the Escherichia coli alpha-haemolysin translocator.
Sebo P; Ladant D
Mol Microbiol; 1993 Sep; 9(5):999-1009. PubMed ID: 7934926
[TBL] [Abstract][Full Text] [Related]
25. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
[TBL] [Abstract][Full Text] [Related]
26. Chemical fatty acylation confers hemolytic and toxic activities to adenylate cyclase protoxin of Bordetella pertussis.
Heveker N; Bonnaffé D; Ullmann A
J Biol Chem; 1994 Dec; 269(52):32844-7. PubMed ID: 7806509
[TBL] [Abstract][Full Text] [Related]
27. Bioengineering of
Ladant D
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260
[TBL] [Abstract][Full Text] [Related]
28. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.
Ross PJ; Lavelle EC; Mills KH; Boyd AP
Infect Immun; 2004 Mar; 72(3):1568-79. PubMed ID: 14977963
[TBL] [Abstract][Full Text] [Related]
29.
Malandra A; Rahman WU; Klimova N; Streparola G; Holubova J; Osickova A; Bariselli S; Sebo P; Osicka R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445770
[TBL] [Abstract][Full Text] [Related]
30. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins.
Gmira S; Karimova G; Ladant D
Res Microbiol; 2001 Dec; 152(10):889-900. PubMed ID: 11766964
[TBL] [Abstract][Full Text] [Related]
31. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
Khelef N; Danve B; Quentin-Millet MJ; Guiso N
Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
[TBL] [Abstract][Full Text] [Related]
32. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin.
Betsou F; Sebo P; Guiso N
Infect Immun; 1993 Sep; 61(9):3583-9. PubMed ID: 8359880
[TBL] [Abstract][Full Text] [Related]
33. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
Dellepiane NI; Manghi MA; Eriksson PV; di Paola G; Cangelosi A
Zentralbl Bakteriol; 1992 Jun; 277(1):65-73. PubMed ID: 1520970
[TBL] [Abstract][Full Text] [Related]
34. Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines.
Sebo P; Osicka R; Masin J
Expert Rev Vaccines; 2014 Oct; 13(10):1215-27. PubMed ID: 25090574
[TBL] [Abstract][Full Text] [Related]
35. High level of soluble expression in Escherichia coli and characterisation of the CyaA pore-forming fragment from a Bordetella pertussis Thai clinical isolate.
Powthongchin B; Angsuthanasombat C
Arch Microbiol; 2008 Feb; 189(2):169-74. PubMed ID: 17846749
[TBL] [Abstract][Full Text] [Related]
36. Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.
Schuler D; Lübker C; Lushington GH; Tang WJ; Shen Y; Richter M; Seifert R
Biochem Pharmacol; 2012 Apr; 83(7):839-848. PubMed ID: 22265637
[TBL] [Abstract][Full Text] [Related]
37. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).
Guermonprez P; Khelef N; Blouin E; Rieu P; Ricciardi-Castagnoli P; Guiso N; Ladant D; Leclerc C
J Exp Med; 2001 May; 193(9):1035-44. PubMed ID: 11342588
[TBL] [Abstract][Full Text] [Related]
38. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.
Thomas MG; Redhead K; Lambert HP
J Infect Dis; 1989 Feb; 159(2):211-8. PubMed ID: 2536779
[TBL] [Abstract][Full Text] [Related]
39. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen.
Guiso N; Rocancourt M; Szatanik M; Alonso JM
Microb Pathog; 1989 Nov; 7(5):373-80. PubMed ID: 2622329
[TBL] [Abstract][Full Text] [Related]
40. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
Osicka R; Osicková A; Basar T; Guermonprez P; Rojas M; Leclerc C; Sebo P
Infect Immun; 2000 Jan; 68(1):247-56. PubMed ID: 10603395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
